在SARS-CoV-2中评估NSAID:免疫调节机制和未来的治疗策略
Said Moshawih1, Qais Jarrar2, Abdul Alim Bahrin1
1PAP Rashidah Sa'adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam.
Heliyon
|February 15, 2024
概括
非类固醇抗炎药 (NSAIDs) 在感染中起着复杂的作用. 虽然降低了炎症,但它们可能会影响免疫防御,因此在控制病毒和细菌疾病时需要谨慎使用.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 非类固醇抗炎药物 (NSAIDs) 通常用于治疗疼痛和炎症.
- SARS-CoV-2 大流行突显了需要了解NSAIDs对病毒和细菌感染的影响.
- 无 NSAID 药物表现出复杂的免疫调节作用,与传染病管理有关.
研究的目的:
- 审查NSAIDs,免疫反应和感染之间的相互作用.
- 检查NSAIDs在SARS-CoV-2和其他感染中的免疫调节机制.
- 为了明确涉及NSAIDs在传染病中的治疗策略.
主要方法:
- 关于NSAIDs对病毒和细菌感染中免疫反应的影响的文献综述.
- 分析NSAIDs在SARS-CoV-2中的作用,包括细胞因子风暴调节.
- 检查NSAIDs在抗瘤免疫力和与其他药物的协同作用方面的潜力.
主要成果:
- 无 NSAIDs 减少炎症,但可能会损害抗病毒防御.
- 它们调节SARS-CoV-2中的细胞因子风暴,并可以增强抗瘤免疫力.
- 世卫组织没有发现NSAIDs与病毒性呼吸道感染恶化之间的联系;特定的NSAID抑制病毒复制.
结论:
- NSAIDs在传染病中具有双重作用,提供了好处,但需要谨慎应用.
- 了解NSAIDs复杂的相互作用对于优化流行病期间治疗至关重要.
- 微妙的应用是必要的,以平衡治疗优势与潜在的不良影响,特别是在弱势群体.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:28Structure-Activity Relationships and Drug Design
720
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
720
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:29Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442